ReviewJHEP reports : innovation in hepatology2025
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease.
Robert F Schwabe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it